Nautilus Biotechnology, Inc. (NAUT) Social Stream



Nautilus Biotechnology, Inc. (NAUT): $2.84

-0.07 (-2.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NAUT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Nautilus Biotechnology Inc (NAUT) Price Targets From Analysts

Use the tables below to see what analysts covering Nautilus Biotechnology Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 2 $13 $13 $13 $3.58 263.13%
2022-02-24 3 $13 $8 $10.5 $3.58 193.3%
2022-03-03 3 $11 $8 $9.5 $3.58 165.36%

NAUT reports an average of 110.09% for its upside potential over the past 28 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-19 NA 13 10 11.5 7.26 58.4%
2021-09-10 NA 13 10 11.5 7.14 61.06%
2021-09-13 NA 13 10 11.5 6.95 65.47%
2021-11-03 2 13 13 13.0 5.84 122.6%
2022-02-24 3 13 8 10.5 3.86 172.02%

NAUT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


NAUT's average broker recommendation rating improved by 0 over the prior 28 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • NAUT has a greater number of analysts covering the stock than 26.89% of all US stocks.
  • Nautilus Biotechnology Inc's average analyst price target is greater than 29.58% of all US stocks.
  • To contextualize these metrics, consider that out of Trading stocks, Nautilus Biotechnology Inc's upside potential (average analyst target price relative to current price) is higher than 294.58% of them.
  • In the context of Trading stocks, Nautilus Biotechnology Inc's variance in analysts' estimates is lower than -44.5% of them.

Stocks similar to Nautilus Biotechnology Inc in the Trading industry regarding analyst recommendations and price targets are MON, MEKA, and MDH.

What is the outlook for NAUT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.431 seconds.